The fact that absence or deficiency of the plasma copper-protein, ceruloplasmin, is almost always associated with the excessive deposits of tissue copper which characterize Wilson's disease has suggested that ceruloplasmin regulates copper absorption or excretion (1) . Based on the in vitro demonstration of reversible dissociation of copper from ceruloplasmin, a hypothesis was proposed of how such regulation could be effected (2) . This stated that if reversible dissociation of copper from ceruloplasmin occurred in the intestinal wall in vivo, a concentration of copper ions would result which could oppose the net transfer of copper ions from the intestinal lumen into the blood. The three experiments reported in this paper were designed to determine whether exchange of ceruloplasmin copper for ionic copper, which is equivalent to reversible dissociation of ceruloplasmin copper, takes place in vivo.
In the first experiment, exchange of ceruloplasmin copper was looked for in patients with Wilson's disease in whom virtually no synthesis of the protein was occurring. The interpretation of this experiment required knowledge of whether the catabolism of ceruloplasmin was detectably different in a normal individual from its catabolism in patients with Wilson's disease. A comparison of the half-life of ceruloplasmin, as one measure of its catabolism, was made in these two types of individuals in the second experiment. In the third experiment, the incorporation of ionic copper into ceruloplasmin was studied in an individual with normal copper metabolism in such a way that incorporation occurring during synthesis of ceruloplasmin could be differentiated from that resulting from copper exchange.
All of our results were compatible with the conclusions that copper entered the ceruloplasmin molecule only at the time of synthesis, and that exchange of ceruloplasmin copper with ionic copper did not occur in vivo. Since it was a corollary of these conclusions that a given copper atom was a label which remained on a ceruloplasmin molecule throughout its life span, we were able to calculate the rate of turnover of ceruloplasmin, and its copper, in To prepare approximately 1 to 2 mc of copper", 60 mg of the nickel' was electroplated as metal onto gold foil that had been silver-soldered to a copper target holder.
(The area covered by the nickel was roughly / X % inch. It varied in thickness from 0.007 to 0.010 inch, which was sufficient to absorb the entire alpha beam.) The target assembly was mounted on a watercooled probe that was inserted into the vacuum chamber of the cyclotron, and the nickel' target was bombarded by the internal beam of 40 Mev alpha particles. At the current of 50 to 60 /ua which resulted, bombardments of 10 to 12 hours were required. For example, 1.4 mc was produced in a 500 pa-hour bombardment, which corresponded to a thick-target yield of 2.8 ,uc per ga-hour.
The target was removed from the cyclotron and the gold foil was separated from the target holder by melting the silver solder. The bombarded nickel was dissolved in a few drops of nitric acid. After addition of 0.5 mg of copper carrier, hold-back carriers of indium, cadmium and cobalt, and 2 or 3 drops of concentrated sulfuric acid, the copper was electroplated at 80°C for 30 minutes onto a platinum electrode. The copper was dissolved from the platinum with nitric acid and was used without sterilization. The processing yield was estimated to be at least 95 per cent. The only radiocontaminant present in significant amount was copper', which constituted initially about 7 per cent of the total radioactivity.
Nitric acid was removed from the solution which remained after the electroplating of copper by evaporation to fumes of sulfur trioxide. The residue was diluted with water, made alkaline with concentrated ammonia, and the nickel' was recovered by electroplating.
The half-life of copper' was determined to be 61.8 ± 0.8 hours. To our knowledge the experiments reported in this paper represent the first use of this isotope in biological research.
Radioactive labeling of ceruloplasmin copper 1. Method A. To a solution of purified ceruloplasmin in physiological saline, ascorbic acid and then copper' nitrate were added. After standing at room temperature for 1.5 hours, approximately 35 per cent of the copper' was found to have been incorporated into the ceruloplasmin of each solution by exchange. The amounts of material used for the two preparations are given in Table I. 2. Method B. Two male volunteers, aged 50 and 64, received 1.0 mg of ethinyl estradiol (Estinyl) daily for 5 days in order to elevate their plasma concentrations of ceruloplasmin (4, 5) . By intravenous injection they were then given, respectively, 3 Quantitative determination of ceruloplasmin. Ceruloplasmin concentrations in serum were measured by determining the oxidase activity of serum toward paraphenylenediamine (2).
Quantitative determination of radioactive copper" and copper. Four-ml aliquots of serum, or smaller aliquots brought to 4 ml by addition of normal saline, were counted in a Nuclear-Chicago DS5-5 well-type scintillation counter by means of a 161A scaler. Discrimination between the 0.184 Mev gamma rays of Cu' (3) and the 0.51 Mev annihilation gamma rays (6) of Cu" was effected by inclusion of a Nuclear-Chicago 1810 radiation analyzer in the circuit. Correction for background and physical decay yielded net corrected counts per minute per milliliter of serum due to each isotope.
Separation of nonceruloplasmin copper. In order to determine the proportion of the radioisotopic copper in serum bound to ceruloplasmin in Experiments I and III, the nonceruloplasmin copper in the serum was made to react with sodium diethyldithiocarbamate (DTC) and the colloidal Cu-DTC complex was adsorbed on a column of activated charcoal, as follows. After dilution of 3 ml of serum with an equal volume of normal saline, 0.6 ml of a 0.1 per cent solution of DTC in saline was added. The mixture was passed through a column of 100 mg of activated charcoal (Norit-A). The 4 ml of effluent which followed the 1.5 ml fore-run had the same concentration of ceruloplasmin as that contained in the 6.6 ml of solution passed over the column, and contained neither free copper nor free DTC. Figure 1 . The values for the half-life of ceruloplasmin given in the figure and in Table II were calculated independently from the results of both the enzymatic and radioactive measurements by the method of least squares. The volumes of distribution of the infused protein (Table II) infused. The concentration of the copper67-labeled ceruloplasmin was measured daily by determining the radioactivity of whole serum, and these results were used to calculate the half-life of ceruloplasmin and its volume of distribution ( Figure 2 and Table II (7), its tight copper-binding, its electrophoretic mobility (7), its lack of antigenicity in human beings,' and its oxidase activity (10) were virtually identical with these properties of ceruloplasmin in whole plasma or serum. Nevertheless, this experiment did not provide evidence that exchange might not have occurred in normal individuals, since the metabolism of ceruloplasmin may differ in the two groups. Consequently, we performed Experiment II in order to compare the half-life of ceruloplasmin, as measured in these patients with Wilson's disease, with the half-life in a normal individual. The half-life of copper67-labeled ceruloplasmin did not differ significantly in a simultaneous test of the values determined in the two patients and in the control subject.5 By this criterion, therefore, ceruloplasmin did not
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In both cases a Iti as great, or greater, might have been found, by chance alone, more than 50 per cent of the time. 4 Insofar as this is indicated by the constancy of the determined half-life and the lack of any clinical reaction incident to repeated infusions of purified ceruloplasmin in G.G. and D.S. over the past 4 years (8, 9) . 5An analysis of covariance (11) was used to test the hypothesis that these three values for the half-life did not differ significantly. An F of 3.129, with 2 and 23 degrees of freedom, was obtained which could occur by chance alone more than 5 per cent of the time.
seem to be metabolized at a different rate in the patients than in the control subject.
Rather similar values for the half-life of ceruloplasmin in patients with Wilson's disease and in control individuals, whether determined in studies with purified ceruloplasmin or with whole blood, have also been found previously. Thus we have reported the half-life of ceruloplasmin to be 3.2 to 4.7 days after the infusion of whole blood (8) , and 5.6 to 7.2 days after administration of unlabeled purified human ceruloplasmin (9) , in patients with Wilson's disease. Gitlin and Hughes [quoted in (12) ], using I131-labeled purified human ceruloplasmin, found half-lives of 5 to 7 days in five chronically ill subjects without Wilson's disease. Half-lives of fibrinogen (13, 14) , the y-globulins (12) , and albumin (15) If, however, a copper atom labels a ceruloplasmin molecule throughout its lifetime we can use our results to calculate the volume of distribution and turnover of ceruloplasmin. The values for volume of distribution are remarkably similar in all three subjects (Table II) . The percentage turnover of ceruloplasmin and of ceruloplasmin copper was calculated in all three subjects from the standard equation (16) (Table II) , and the fact that the copper content of the protein is 0.34 per cent (7) . The value of 142 mg for the daily turnover of ceruloplasmin in the control subject, J.M., corresponds to 0.5 mg of copper incorporated into ceruloplasmin daily. This must be close to the amount of copper which is absorbed from the 2 to 5 mg of copper ingested in the diet (17) . Thus it seems that much of the absorbed dietary copper in a normal individual may ultimately be bound to a ceruloplasmin molecule of 151,000 mol wt. Such bound copper should be confined largely to the vascular compartment, and the volume of distribution of 3.97 L found in J.M. indicates that it is.
Despite the apparent congruence of the amount of copper absorbed and that which is used daily for the synthesis of ceruloplasmin, our results do not greatly clarify the physiological role of ceruloplasmin and its relationship to Wilson's disease. 4. The amount of copper incorporated daily into ceruloplasmin in a control subject corresponds closely to the amount of copper absorbed from the dietary intake.
